Market Overview

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of ARMO BioSciences, Inc. Buyout


Rigrodsky & Long, P.A.:

  • Do you own shares of ARMO BioSciences, Inc. (NASDAQ GS: ARMO)?
  • Did you purchase any of your shares prior to May 10, 2018?
  • Do you think the proposed buyout is fair?
  • Do you want to discuss your rights?

& Long, P.A.
announces that it is investigating potential legal
claims against the board of directors of ARMO BioSciences, Inc. ("ARMO"
or the "Company") (NASDAQ GS: ARMO)
regarding possible breaches of fiduciary duties and other violations of
law related to the Company's entry into an agreement to be acquired by
Eli Lilly and Company ("Lilly") (NYSE: LLY)
in a transaction valued at approximately $1.6 billion. Under the terms
of the agreement, shareholders of ARMO will receive $50.00 in cash for
each share of ARMO common stock.

If you own common stock of ARMO and purchased any shares before May 10,
2018, if you would like to learn more about this investigation, or if
you have any questions concerning this announcement or your rights or
interests, please contact Seth D. Rigrodsky or Gina M. Serra at
Rigrodsky & Long, P.A., 300 Delaware Avenue, Suite 1220, Wilmington,
Delaware 19801, by telephone at (888) 969-4242, or by e-mail at

& Long, P.A.
, with offices in Wilmington, Delaware, Garden City,
New York, and San Francisco, California, has recovered hundreds of
millions of dollars on behalf of investors and achieved substantial
corporate governance reforms in numerous cases nationwide, including federal
securities fraud actions, shareholder class actions, and shareholder
derivative actions

Attorney advertising. Prior results do not guarantee a similar outcome.

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial